Internal Medicine CME

Credits: 1.00 CME
Medical Learning Institute, Inc.
New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer
March 9, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
RCC MasterClass and Clinical Consult: Remodeling the Treatment Algorithm With Novel Immune and Targeted Therapies
Toni K. Choueiri, MD
March 4, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis: Expert Insight on Clinical Decision-Making in an Expanding Therapeutic Landscape
Philip J. Mease, MD, MACR
March 4, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Right Moves in the Evolving Prostate Cancer Therapeutic Landscape: Expert Guidance on Treatment Sequencing and Selection for Effective Management Across the Disease Continuum
Robert Dreicer, MD, MS, MACP, FASCO
March 3, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
Professor Thomas Powles, MBBS, MRCP, MD
March 3, 2021
Credits: 0.50 CME / MOC / CC
Medical Learning Institute, Inc.
Improving the Management of Chronic Rhinosinusitis With Nasal Polyps: Practical Strategies for Selecting the Right Patients for Targeted Treatment
Stella Lee, MD
February 26, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
How to Manage JAK Inhibition in Patients Undergoing HCT: Applying the Latest Clinical Evidence to Improve Patient Outcomes in Myelofibrosis
Ruben A. Mesa, MD, FACP
February 26, 2021
Credits: 0.50 ABO / CME / MOC
Medical Learning Institute, Inc.
A Quick Look at Recent Evidence for Improving Outcomes in Patients With Diabetic Retinopathy Using Anti-VEGF Therapy
Jennifer I. Lim, MD, FARVO
February 25, 2021
Credits: 0.50 CME
Penn State College of Medicine
Optimizing Maintenance Immunosuppressive Therapy in Kidney Transplantation: Examining Current and Future Strategies to Preserve Graft Function and Maximize Long-Term Outcomes
Titte R. Srinivas, MD, FAST
February 25, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expanding the Benefits of Immuno-Oncology to More Patients With Solid Tumors Through Novel Rational Targets and Combinations
Jason J. Luke, MD, FACP
February 24, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics
Corey Cutler, MD, MPH, FRCP(C) / Miguel-Angel Perales, MD
February 23, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
Betting on CAR-T Cell Therapy: Expert Perspectives on Effective Integration Strategies and Achieving Improved Outcomes Across Hematologic Cancers
Michael R. Bishop, MD
February 18, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT
Robert Z. Orlowski, MD, PhD
February 17, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
Charting Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT
February 16, 2021
Credits: 0.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care
Reynold A. Panettieri, Jr., MD
February 15, 2021
Credits: 1.25 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Changing the Game for Patients With ES-SCLC Through Multidisciplinary Collaboration: Best Practices to Optimize Immunotherapy-Based Approaches and Improve Patient Outcomes
Stephen V. Liu, MD
February 12, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Taking an Individualized Approach to Neovascular Age-Related Macular Degeneration: Examining the Evidence to Improve Patient Outcomes
Rishi P. Singh, MD
February 12, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A New Dawn in the Therapeutic Management of Biliary Cancers: Integrating Precision Medicine With New and Emerging Targeted Strategies
Milind Javle, MD
February 11, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches
Richard S. Finn, MD
February 9, 2021
Credits: 1.75 CME / MOC
Medical Learning Institute, Inc.
Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies
Axel Grothey, MD
February 8, 2021

Pages

Education Collections